Plasmatic Exosome Number and Size Distinguish Prostate Cancer Patients From Healthy Individuals: A Prospective Clinical Study.

Logozzi, Mariantonia; Mizzoni, Davide; Di Raimo, Rossella; Giuliani, Alessandro; Maggi, Martina; Sciarra, Alessandro; Fais, Stefano

Logozzi, Mariantonia; Mizzoni, Davide; Di Raimo, Rossella; Giuliani, Alessandro; Maggi, Martina; Sciarra, Alessandro; Fais, Stefano.

Afiliação

Logozzi M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Mizzoni D; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Di Raimo R; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Giuliani A; Environment and Health Department, Istituto Superiore di Sanità, Rome, Italy.
Maggi M; Department of Urology, Policlinico Umberto I, Università La Sapienza, Rome, Italy.
Sciarra A; Department of Urology, Policlinico Umberto I, Università La Sapienza, Rome, Italy.
Fais S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

Front Oncol ; 11: 727317, 2021.

Article em En | MEDLINE | ID: mdl-34745949

Palavras-chave

NTA; liquid biopsy; plasmatic exosomes; prostate cancer; screening test

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google